We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Biogen Inc | LSE:0R1B | London | Ordinary Share | BIOGEN INC ORD SHS |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 9.84B | 1.16B | 8.0132 | 19.47 | 40.23B |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
08:19:13 | O | 6 | 155.94 | USD |
Date | Time | Source | Headline |
---|---|---|---|
19/11/2024 | 06:00 | UKREG | Dapirolizumab Pegol Phase 3 Data Presented at the American College of.. |
14/11/2024 | 16:23 | UKREG | Eisai Receives Positive Opinion from the CHMP in the European Union for.. |
30/10/2024 | 23:30 | UKREG | Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting.. |
29/10/2024 | 22:00 | UKREG | Biogen and Neomorph Announce Multi-Target Research Collaboration to.. |
29/10/2024 | 12:00 | UKREG | Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer |
28/10/2024 | 12:30 | UKREG | Michael McDonnell, Executive Vice President and Chief Financial Officer to.. |
27/10/2024 | 00:15 | UKREG | Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in.. |
24/10/2024 | 11:30 | UKREG | Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease.. |
22/10/2024 | 11:30 | UKREG | Biogen Announces Late Breaker and New Data Presentations at American.. |
09/10/2024 | 11:30 | UKREG | Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab.. |
Biogen (0R1B) Share Charts1 Year Biogen Chart |
|
1 Month Biogen Chart |
Intraday Biogen Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
08:19:13 | 155.94 | 6 | 0.00 | O |
08:19:13 | 155.95 | 7 | 0.00 | O |
08:03:08 | 154.78 | 2 | 0.00 | O |
08:02:48 | 154.78 | 2 | 0.00 | O |
08:02:02 | 155.03 | 3 | 0.00 | O |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions